Searched for
LIVER CIRRHOSIS TREATMENT
Should they now be part of a long-term investing framework? 7 healthcare stocks with upside potential of up to 25%India’s healthcare market may grow steadily, but hospital chains can grow faster as formalisation continues. Healthcare is all about market...- How much health insurance cover do you need? Here’s the ideal cover for ₹10 lakh, ₹20 lakh, ₹30 lakh, and ₹50 lakh annual income as per expertsSoaring medical costs, with surgery expenses up 250-300%, necessitate robust health insurance. Experts advise a minimum of Rs 10-15 lakh fo...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- 5 mid-cap stocks from different sectors with an upside potential of 13 to 24% in one year, according to analystsWhen mid-caps were rising, every concern on valuation was treated as unnecessary caution. Investors who advised patience were told they wer...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Volatility as opportunity, depends on framework of mind: 5 mid-caps from different sectors with upside potential of up to 31%The Indian stock market is no longer correcting only because of sentiment. It is now adjusting to the possibility of weaker numbers in the ...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Time to take the first step to become a contrarian? 4 mid-cap stocks from different sectors with upside potential up to 21%As the risk created by the US-Iran war keeps crude oil prices elevated, the list of stocks where investors can deploy fresh money with comf...
- AbbVie loses patent plea for Hep C drugThe Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...
- Man with normal liver tests thought he was perfectly healthy. A routine ultrasound gave him the shock of his lifeA man with normal blood tests was shocked to discover liver cancer after an ultrasound, despite only experiencing gas and discomfort. Dr. P...
- NAFLD vs AFLD: What causes fatty liver problems and how to prevent damage in early stagesFatty liver disease occurs when excess fat builds up in the liver, leading to potential long-term damage. It is classified into two main ty...
- Don't ignore fatty liver disease. Swollen feet, excessive sleepiness can be signs of underlying failureThere is an increasing incidence of cancer among patients with fatty liver as well.
- Zydus rises on regulator’s nod for drug to treat liver diseaseShares of the company closed at Rs 263.55 on the bourse.
- Zydus Cadila gets DCGI nod for world's first drug to treat liver diseaseThe Ahmedabad-based company said the approved product is the first ever drug anywhere in the world for treatment of Non-Cirrhotic Non-Alcoh...
- Mylan wants to capture chronic Hep B marketThe drug was approved in India in November this year and is the “first” to be approved in eight years for the management of this infection ...
- 95% of hepatitis patients don't notice infectionConcerns are not limited to India. The assessment shows the infection, as well as is its consequent mortality, increasing rapidly worldwide.
- Abbott launches Hepatitis C awareness, diagnosis programmeHepatitis C virus causes chronic infection leading to cirrhosis and may cause liver cancer.
- 18-year-old liver donor becomes Rajasthan's organ ambassadorThe young girl was chosen as the state's brand ambassador of organ transplant by Rajasthan health minister Rajendra Rathore.
Load More
